Progress in Pediatric Cardiology
Volume 25, Issue 1 , Pages 51-56 , April 2008

Signalosomes as therapeutic targets

  • Alejandra Negro

      Affiliations

    • Cardiac Signal Transduction and Cellular Biology Laboratory, Department of Medicine and Pediatrics, University of Miami Miller School of Medicine, R198, P.O. Box 016960, Miami, FL 33101, United States
    • ,
  • Kimberly Dodge-Kafka

      Affiliations

    • Calhoun Center for Cardiology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, United States
    • ,
  • Michael S. Kapiloff

      Affiliations

    • Cardiac Signal Transduction and Cellular Biology Laboratory, Department of Medicine and Pediatrics, University of Miami Miller School of Medicine, R198, P.O. Box 016960, Miami, FL 33101, United States
    • Corresponding Author InformationCorresponding author. Cardiac Signal Transduction and Cellular Biology Laboratory, University of Miami Miller School of Medicine, R198, P.O. Box 016960, Miami, FL 33101, United States. Tel.: +1 305 243 7863; fax: +1 305 243 3906.

References 

  1. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006;7:589–600
  2. Clerk A, Cullingford TE, Fuller SJ, et al. Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses. J Cell Physiol. 2007;212:311–322
  3. Steinberg SF, Brunton LL. Compartmentation of g protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol. 2001;41:751–773
  4. Smith FD, Langeberg LK, Scott JD. The where's and when's of kinase anchoring. Trends Biochem Sci. 2006;31:316–323
  5. Bauman AL, Michel JJ, Henson E, et al. The mAKAP signalosome and cardiac myocyte hypertrophy. IUBMB Life. 2007;59:163–169
  6. Diviani D, Baisamy L, Appert-Collin A. AKAP-Lbc: a molecular scaffold for the integration of cyclic AMP and Rho transduction pathways. Eur J Cell Biol. 2006;85:603–610
  7. Barnes S, Shields B, Bonney W, et al. The pediatric cardiology pharmacopoeia: 2004 update. Pediatr Cardiol. 2004;25:623–646
  8. Buxton IL, Brunton LL. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem. 1983;258:10233–10239
  9. Michel JJ, Scott JD. Akap mediated signal transduction. Annu Rev Pharmacol Toxicol. 2002;42:235–257
  10. Fraser IDC, Tavalin SJ, Lester LB, et al. A novel lipid-anchored A-kinase Anchoring Protein facilitates cAMP-responsive membrane events. EMBO J. 1998;17:2261–2272
  11. Hulme JT, Westenbroek RE, Scheuer T, et al. Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation. Proc Natl Acad Sci USA. 2006;103:16574–16579
  12. McCartney S, Little BM, Langeberg LK, et al. Cloning and characterization of A-kinase anchor protein 100 (AKAP100). A protein that targets A-kinase to the sarcoplasmic reticulum. J Biol Chem. 1995;270:9327–9333
  13. Yang J, Drazba JA, Ferguson DG, et al. A-kinase anchoring protein 100 (AKAP100) is localized in multiple subcellular compartments in the adult rat heart. J Cell Biol. 1998;142:511–522
  14. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365–376
  15. Kapiloff MS, Schillace RV, Westphal AM, et al. mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci. 1999;112:2725–2736
  16. Kapiloff MS, Jackson N, Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci. 2001;114:3167–3176
  17. Pare GC, Easlick JL, Mislow JM, et al. Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp Cell Res. 2005;303:388–399
  18. Zhang Q, Bethmann C, Worth NF, et al. Nesprin-1 and -2 are involved in the pathogenesis of Emery–Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet. 2007;
  19. Dodge KL, Khouangsathiene S, Kapiloff MS, et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001;20:1921–1930
  20. Terrin A, Di Benedetto G, Pertegato V, et al. PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases. J Cell Biol. 2006;175:441–451
  21. Carlisle Michel JJ, Dodge KL, Wong W, et al. PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex. Biochem J. 2004;381:587–592
  22. Dodge-Kafka KL, Soughayer J, Pare GC, et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature. 2005;437:574–578
  23. Yan C, Ding B, Shishido T, et al. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res. 2007;100:510–519
  24. Nicol RL, Frey N, Pearson G, et al. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 2001;20:2757–2767
  25. MacKenzie SJ, Baillie GS, McPhee I, et al. ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. J Biol Chem. 2000;275:16609–16617
  26. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res. 2002;91:1103–1113
  27. Bers DM. Cardiac ryanodine receptor phosphorylation: target sites and functional consequences. Biochem J. 2006;396:e1–e3
  28. Wehrens XH, Lehnart SE, Reiken S, et al. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci U S A. 2006;103:511–518
  29. Wu X, Bers DM. Sarcoplasmic reticulum and nuclear envelope are one highly interconnected Ca2+ store throughout cardiac myocyte. Circ Res. 2006;99:283–291
  30. Pare GC, Bauman AL, McHenry M, et al. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci. 2005;118:5637–5646
  31. Wilkins BJ, Molkentin JD. Calcium–calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun. 2004;322:1178–1191
  32. Appert-Collin A, Cotecchia S, Nenniger-Tosato M, et al. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A. 2007;104:10140–10145
  33. Carr DW, Hausken ZE, Fraser ID, et al. Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII- binding domain. J Biol Chem. 1992;267:13376–13382
  34. Newlon MG, Roy M, Morikis D, et al. A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes. EMBO J. 2001;20:1651–1662
  35. Diviani D, Soderling J, Scott JD. AKAP-Lbc Anchors Protein Kinase A and Nucleates Galpha 12-selective Rho- mediated Stress Fiber Formation. J Biol Chem. 2001;276:44247–44257
  36. Diviani D, Abuin L, Cotecchia S, et al. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. EMBO J. 2004;23:2811–2820
  37. Jin J, Smith FD, Stark C, et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol. 2004;14:1436–1450
  38. Maruyama Y, Nishida M, Sugimoto Y, et al. Galpha(12/13) mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy. Circ Res. 2002;91:961–969
  39. Carnegie GK, Smith FD, McConnachie G, et al. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol Cell. 2004;15:889–899
  40. de Fougerolles A, Vornlocher HP, Maraganore J, et al. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 2007;6:443–453
  41. Dodge-Kafka KL, Kapiloff MS. The mAKAP signaling complex: integration of cAMP, calcium, and MAP kinase signaling pathways. Eur J Cell Biol. 2006;85:593–602
  42. Martinez-Martinez S, Redondo JM. Inhibitors of the calcineurin/NFAT pathway. Curr Med Chem. 2004;11:997–1007
  43. Yu H, van Berkel TJ, Biessen EA. Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders. Cardiovasc Drug Rev. 2007;25:175–187

☆ This work is supported by a grant from the National Heart, Lung, and Blood Institute.

PII: S1058-9813(07)00167-1

doi: 10.1016/j.ppedcard.2007.11.012

Progress in Pediatric Cardiology
Volume 25, Issue 1 , Pages 51-56 , April 2008

Article Tools

* Image Usage & Resolution